Immunic's slogan is: "Immunic is a biotechnology company developing small molecule therapies for chronic inflammatory and autoimmune diseases". The company's Privacy Policy can be found at: https://imux.com/privacy-policy/
Immunic Therapeutics
Immunic is a biotechnology company developing small molecule therapies for chronic inflammatory and autoimmune diseases
Founded 2016
United States
91 employees
Post-IPO Equity
Total: $520.00M
Biotechnology, Health and Wellness +1
United States
91 employees
Post-IPO Equity
Total: $520.00M
Biotechnology, Health and Wellness +1
General Information
Company Name
Immunic Therapeutics
Founded Year
2016
Location
United States
United States
Employees
91
Industries
Biotechnology, Health and Wellness, Life Sciences
Funding Stage
Post-IPO Equity
BounceWatch is an independent company data service, not affiliated with Immunic Therapeutics. To contact Immunic Therapeutics, visit imux.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Immunic Therapeutics compare?
A PDF of Immunic Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Immunic Therapeutics soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
United States Market
Biotechnology
Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.
Event Participation
Oct 08, 2026
Immunic Therapeutics participated in a recent interview with European, sharing their vision to understand MS patients better.
About Immunic Therapeutics
Business keywords: small molecule therapies, chronic inflammatory diseases, autoimmune diseases, clinical pipeline, oral administration, Nasdaq listed, drug development, precision medicine, pharmaceuticals, immunology, autoimmune disorders
Funding Rounds & Investors (10)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Post IPO Equity | $240.00M | 6 |
|
04 Jan 2024 |
| Post IPO Equity | $60.00M | 10 |
|
10 Oct 2022 |
| Post IPO Equity | $45.00M | - |
|
15 Jul 2021 |
| Post IPO Equity | $103.50M | - |
|
04 Aug 2020 |
| Post IPO Equity | $25.00M | - |
|
09 Jun 2020 |
| Post IPO Equity | $15.00M | - |
|
23 Apr 2020 |
| Grant | Undisclosed | 1 |
German Federal Ministry of Education and Research
|
01 Aug 2019 |
| Series A | €10.00M | 5 |
|
05 Sep 2017 |
| Series A | €4.00M | 3 |
|
01 Feb 2017 |
| Series A | €17.50M | 4 |
|
27 Sep 2016 |
Immunic Therapeutics Alternatives & Competitors
View All Alternatives
Immunic Therapeutics vs
Nuvig Therapeutics Inc.
United States
Rebalancing Immune Function for Chronic Inflammatory and Autoimmune Diseases
Series A
24 employees
Biotechnology, Health Care
Immunic Therapeutics vs
Nimbus Therapeutics
United States
We develop breakthrough medicines for patients through precision small molecule design.
Private Equity
99 employees
Biotechnology, Health Care
Immunic Therapeutics vs
Kezar Life Sciences
United States
Pioneering first-in-class, small-molecule therapies for immune-mediated and oncologic disorders
Post-IPO Equity
71 employees
Health Care, Health and Wellness
Verona Pharma
FAQ About Immunic Therapeutics
Immunic is a biotechnology company developing small molecule therapies for chronic inflammatory and autoimmune diseases
Immunic Therapeutics was founded in 2016.
Immunic Therapeutics is headquartered in United States.
Immunic Therapeutics operates in Biotechnology, Health and Wellness and Life Sciences. Its work centres on small molecule therapies, chronic inflammatory diseases, autoimmune diseases and clinical pipeline.
Immunic Therapeutics has approximately 91 employees.
Immunic Therapeutics has completed 10 funding rounds, raising a total of $520.00M. The latest funding stage is Post-IPO Equity.
Top alternatives and competitors to Immunic Therapeutics include Nuvig Therapeutics Inc., Nimbus Therapeutics, Kezar Life Sciences, Verona Pharma, Evommune. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Immunic Therapeutics and Nuvig Therapeutics Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Source: BounceWatch company record for Immunic Therapeutics, https://bouncewatch.com/company/immunic-therapeutics, updated 4 July 2026. When citing, please name BounceWatch and link this page.
